Heritable Risk and Protective Genetic Components of Glaucoma Medication Non-Adherence
Glaucoma is the leading cause of irreversible blindness, affecting 76 million globally. It is characterized by irreversible damage to the optic nerve. Pharmacotherapy manages intraocular pressure (IOP) and slows disease progression. However, non-adherence to glaucoma medications remains problematic,...
Main Authors: | Julie L. Barr, Michael Feehan, Casey Tak, Leah A. Owen, Robert C. Finley, Parker A. Cromwell, John H. Lillvis, Patrice M. Hicks, Elizabeth Au, Michael H. Farkas, Asher Weiner, Andrew L. Reynolds, Sandra F. Sieminski, Richard M. Sherva, Mark A. Munger, Murray H. Brilliant, Margaret M. DeAngelis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/6/5636 |
Similar Items
-
Heritability of Blood Pressure in an Iranian Population
by: M Saadat, et al.
Published: (2001-07-01) -
A Pilot Study Exploring the Impact of a Primary Medication Non-Adherence Intervention among Four Chronic Disease States in One Regional Division of a Large Community Pharmacy Chain
by: Danya H. Wilson, et al.
Published: (2023-01-01) -
A study of adherence and non-adherence to antipsychotic medication in patients of Schizophrenia
by: B Khar Prerna, et al.
Published: (2020-01-01) -
Real-Time Monitoring and Point-of-Care Testing: A Review of the Current Landscape of PrEP Adherence Monitoring
by: Hannaford A, et al.
Published: (2021-02-01) -
Validating the Modified Drug Adherence Work-Up (M-DRAW) Tool to Identify and Address Barriers to Medication Adherence
by: Sun Lee, et al.
Published: (2017-09-01)